Ketamine FDA - Search News

Ketamine Nasal Spray Approved

Fortune on MSN · 3h

FDA approves Johnson & Johnson’s ketamine-derived nasal spray for depression as standalone treatment

The announcement was welcome news for those with major depressive disorder, affecting an estimated 8.3% of the adult population.

CNN on MSN · 1d

FDA approves standalone use of J&J’s ketamine-derived depression treatment

The U.S. Food and Drug Administration expanded approval for Johnson & Johnson’s nasal spray, Spravato, to allow it to be used as a standalone treatment for patients with severe depression, the company said on Tuesday.

Fox Business · 1d

J&J's ketamine-derived nasal spray approved by FDA to treat depression

Johnson & Johnson's ketamine-derived nasal spray has been approved as a standalone treatment to fight depression for those who had an inadequate response to oral antidepressants.

J&J’s ketamine-based drug approved as standalone treatment

"Treatment-resistant depression can be very complicated, especially for patients who do not respond to oral antidepressants ...

US Weekly on MSN6d

What Celebrities and Doctors Have Said About Ketamine Use: Chrissy Teigen, Matthew Perry, More

Celebrities like Chrissy Teigen and Matthew Perry have been open about using ketamine for their mental health – here's what ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results